Microsoft and Anthropic Discuss Custom AI Chip Deal Amidst Strategic Investments Space Stocks Rally as SpaceXs Latest Starship Test Fuels PreIPO Speculation Dow Leads Wall Street Higher as Healthcare and Tech Stocks Rally AARP Releases April 2026 Employment Data Digest Trends for Older Workers Under Review ADP Reports Private Payrolls Rose 109000 in April Exceeding Expectations Hindalco TVS Motor Eicher Motors NTPC Lead Stocks in Focus on May 25 2026 Prestige Consumer Healthcare Inc Q1 2026 Earnings EPS Miss Overshadows Steady Operations UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter BYRN Q1 2026 Earnings EPS Misses Estimates Stock Advances on Strategic Progress AVAV Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Strategic Outlook Jiayin Group Q4 2024 Earnings Strong EPS Performance Amid Market Headwinds PDPA Q4 2025 Earnings EPS Slightly Below Estimates Preferred Stock Unchanged enCore Energy Corp EU Edges Higher Amid Modest Uranium Sector Recovery Vince Holding Corp VNCE Advances 263 as Stock Approaches Key Resistance BillionToOne Inc BLLN Surges 83 as Momentum Builds Toward Key Resistance Power Solutions International PSIX Sees Slight Decline as Stock Tests Key Support Levels Ecolab ECL Edges Higher as Support Holds Resistance in Sight Bitcoin Slides Below 77000 Amid Escalating Geopolitical Tensions and ETF Withdrawals SEB Q1 2026 Earnings Strong EPS Performance Amid Limited Visibility Getty Images GETY Edges Higher Amid Volatility Key Support and Resistance Levels in Focus ATO Q1 2026 Earnings EPS Beats Estimates Amidst Operational Discipline ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Seven Hills Realty Trust SEVN Q1 2026 Earnings Narrow EPS Beat Fails to Lift Stock as Market Stays Cautious UWMC Q1 2026 Earnings EPS Surges Past Estimates Amidst Quiet Revenue Reporting CAG Q1 2026 Earnings EPS Miss Weighs on Shares Amid Cost Pressures AMTB Q1 2026 Earnings Earnings Slightly Miss Estimates Stock Edges Lower MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline